Amanote Research
Register
Sign In
Safety and Efficacy of Guselkumab in Japanese Patients With Moderate-To-Severe Plaque Psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study
British Journal of Dermatology
- United Kingdom
doi 10.1111/bjd.16236
Full Text
Open PDF
Abstract
Available in
full text
Categories
Dermatology
Medicine
Date
January 17, 2018
Authors
O. Nemoto
K. Hirose
S. Shibata
K. Li
H. Kubo
Publisher
Wiley
Related search
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients With Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
SKIN The Journal of Cutaneous Medicine
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Ixekizumab Efficacy and Safety in Moderate-To-Severe Genital Psoriasis
British Journal of Dermatology
Dermatology
Medicine
